[Drug delivery systems in gene therapy]

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Nonviral vectors present a simpler and safer alternative to viral systems for in vivo gene delivery.
• Liposomes and receptor-mediated polycation systems are key nonviral carriers for plasmid DNA.
• Significant barriers impede the efficiency of in vivo gene delivery using nonviral systems.

Purpose of the Study:

• To review the current status of nonviral plasmid DNA delivery systems for in vivo gene therapy.
• To discuss the challenges and future perspectives in the field of nonviral gene delivery.

Main Methods:

• Focus on liposomes and receptor-mediated polycation systems as nonviral vectors.
• Analysis of factors influencing in vivo gene delivery and expression.
• Review of current literature on nonviral gene therapy strategies.

Main Results:

• Nonviral vectors offer advantages over viral systems, including reduced risks.
• Successful in vivo gene delivery depends on overcoming multiple biological and physical barriers.
• Factors such as DNA condensation, particle size, and cellular interactions are critical.

Conclusions:

• Nonviral vectors hold significant promise for in vivo gene therapy applications.
• Further research is needed to optimize nonviral systems and overcome delivery barriers.
• Advancements in nonviral gene delivery are crucial for the future of genetic medicine.